Bone marrow pilot study comparing BMT to peripheral blood stem cell transplants to begin.
Executive Summary
BONE MARROW COMPARISON TO PERIPHERAL BLOOD STEM CELL TRANSPLANTATION through large-scale trials may begin in two years if a pilot study by the National Marrow Donor Program is successful. A clinical trial, slated to begin in late September, will compare secondary donation of allogeneic PBSCs collected by apheresis to standard marrow donation. PBSCs will be stimulated with recombinant granulocyte-colony stimulating factor (Amgen's Neupogen, filgrastim).